TEST BANK FOR Advanced Practice Nursing
v v v v v
in the Care of Older Adults, 2nd Edition
v v v v v v v v v
by Laurie Kennedy-Malone, Verified Chapters 1 - 19, Complete
v v v v v v v v
,
, Answers at the end of the Chapter
v v v v v v v
Chapter 1: Changes with Aging
v v v v
Multiple vChoice
Identify vthe vchoice vthat vbest vcompletes vthe vstatement vor vanswers vthe vquestion.
1. The vmajor vimpact vof vthe vphysiological vchanges vthat voccur vwith vaging vis:
A. Reduced vphysiological vreserve
B. Reduced vhomeostatic vmechanisms
C. Impaired vimmunological vresponse
D. All vof vthe vabove
2. The vstrongest vevidence vregarding vnormal vphysiological vaging vis vavailable vthrough:
, A. Randomized vcontrolled vclinical vtrials
B. Cross-sectional vstudies
C. Longitudinal vstudies
D. Case vcontrol vstudies
vv v 3. v All vof vthe vfollowing vstatements vare vtrue vabout vlaboratory
values vin volder vadultsexcept:
A. Reference vranges vare vpreferable
B. Abnormal vfindings vare voften vdue vto vphysiological vaging
C. Normal vranges vmay vnot vbe vapplicable vfor volder vadults
D. Reference vvalues vare vnot vnecessarily vacceptable vvalues
vv v 4. v Biochemical vindividuality vis vbest vdescribed vas:
A. Each vindividual’s vvariation vis voften vmuch vgreater vthan vthat vof va vlarger vgroup
B. The vunique vbiochemical vprofile vof va vselected vpopulation
C. The vtruly v“normal” vindividual—falling vwithin vaverage vrange
D. Each vindividual’s vvariation vis voften vmuch vsmaller vthan vthat vof va vlarger vgroup
vv v 5. v Polypharmacy vis vbest vdescribed vas vtaking:
A. More vthan vnine vmedications vper vday
B. More vthan vfive vmedications vper vday
v v v v v
in the Care of Older Adults, 2nd Edition
v v v v v v v v v
by Laurie Kennedy-Malone, Verified Chapters 1 - 19, Complete
v v v v v v v v
,
, Answers at the end of the Chapter
v v v v v v v
Chapter 1: Changes with Aging
v v v v
Multiple vChoice
Identify vthe vchoice vthat vbest vcompletes vthe vstatement vor vanswers vthe vquestion.
1. The vmajor vimpact vof vthe vphysiological vchanges vthat voccur vwith vaging vis:
A. Reduced vphysiological vreserve
B. Reduced vhomeostatic vmechanisms
C. Impaired vimmunological vresponse
D. All vof vthe vabove
2. The vstrongest vevidence vregarding vnormal vphysiological vaging vis vavailable vthrough:
, A. Randomized vcontrolled vclinical vtrials
B. Cross-sectional vstudies
C. Longitudinal vstudies
D. Case vcontrol vstudies
vv v 3. v All vof vthe vfollowing vstatements vare vtrue vabout vlaboratory
values vin volder vadultsexcept:
A. Reference vranges vare vpreferable
B. Abnormal vfindings vare voften vdue vto vphysiological vaging
C. Normal vranges vmay vnot vbe vapplicable vfor volder vadults
D. Reference vvalues vare vnot vnecessarily vacceptable vvalues
vv v 4. v Biochemical vindividuality vis vbest vdescribed vas:
A. Each vindividual’s vvariation vis voften vmuch vgreater vthan vthat vof va vlarger vgroup
B. The vunique vbiochemical vprofile vof va vselected vpopulation
C. The vtruly v“normal” vindividual—falling vwithin vaverage vrange
D. Each vindividual’s vvariation vis voften vmuch vsmaller vthan vthat vof va vlarger vgroup
vv v 5. v Polypharmacy vis vbest vdescribed vas vtaking:
A. More vthan vnine vmedications vper vday
B. More vthan vfive vmedications vper vday
